These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9782064)
21. Open clinical uro-oncology trials in Canada. Rodrigues G; Winquist E Can J Urol; 2011 Jun; 18(3):5751-6. PubMed ID: 21703055 [No Abstract] [Full Text] [Related]
22. Open clinical uro-oncology trials in Canada. Winquist E; Rodrigues G Can J Urol; 2011 Aug; 18(4):5849-55. PubMed ID: 21854720 [No Abstract] [Full Text] [Related]
23. Open clinical uro-oncology trials in Canada. Mackenzie MJ; Rodrigues G; Winquist E Can J Urol; 2009 Jun; 16(3):4706-11. PubMed ID: 19497189 [No Abstract] [Full Text] [Related]
24. Open clinical uro-oncology trials in Canada. Rodrigues G; Winquist E Can J Urol; 2010 Dec; 17(6):5494-9. PubMed ID: 21172119 [No Abstract] [Full Text] [Related]
25. [Tumor recurrence in the upper urinary tract after total cystectomy]. Bouchot O; Zerbib M Prog Urol; 2002 Nov; 12(5):1085-91. PubMed ID: 12536930 [No Abstract] [Full Text] [Related]
26. [New therapies for urologic cancer diseases. The Danish Society of Urology]. Lund L; Borre M; Hermann GG; Svolgaard N; Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675 [No Abstract] [Full Text] [Related]
27. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract]. Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863 [TBL] [Abstract][Full Text] [Related]
29. Triplicity of the malignant tumor of the urinary bladder. Krska A; Simon V; Klemenc J; Votocek E; Hrubý M Sb Lek; 1994; 95(3):185-8. PubMed ID: 8711348 [TBL] [Abstract][Full Text] [Related]
30. Open clinical uro-oncology trials in Canada. Mackenzie M; Rodrigues G; Winquist E Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993 [No Abstract] [Full Text] [Related]
31. [Urology]. Jichlinski P Rev Med Suisse; 2014 Jan; 10(412-413):127-9. PubMed ID: 24558917 [TBL] [Abstract][Full Text] [Related]
32. [Update on the medical treatment of urologic tumors]. Culine S Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634 [No Abstract] [Full Text] [Related]
33. [An 18-year follow-up of a patient with four asynchronous malignant tumors of the urogenital system]. Alferov SM; Grishin MA; Odintsov SV; Chuprik-Malinovskaia TP Urologiia; 2014; (1):68-72. PubMed ID: 24772778 [No Abstract] [Full Text] [Related]
34. [The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney and prostate cancers]. Neuzillet Y; Négrier S; Fizazi K; Pignot G; Benchikh El Fegoun A; Guillotreau J; Culine S Prog Urol; 2010 Mar; 20 Suppl 1():S84-9. PubMed ID: 20493454 [TBL] [Abstract][Full Text] [Related]
35. [Monoclonal antibodies in diagnosis and therapy]. Huland H; Hammerer P Immun Infekt; 1989 Feb; 17(1):28. PubMed ID: 2647624 [TBL] [Abstract][Full Text] [Related]
36. [Catherer embolization of malignant urological tumors]. Haertel M; Zaunbauer W; Zingg E Schweiz Med Wochenschr; 1977 Apr; 107(17):584-8. PubMed ID: 558649 [TBL] [Abstract][Full Text] [Related]